Smoking Related Disorders

	09/25/2009	Maintenance Therapy or Exposure to Active Treatment? A Question for the NSCLC Setting
	09/08/2009	The Evolving Treatment Paradigm for Advanced NSCLC: Clinical Highlights From the 2009 Oncology Meeting in Orlando
	09/08/2009	Do New Data Justify a Role for Maintenance Therapy in Advanced NSCLC?
	09/08/2009	Are There Clinically Relevant Correlations Between Biomarker Status and Benefit From Targeted Therapies in Advanced NSCLC?
	09/08/2009	Which Novel Agents and Combinations Are Showing Promise in the Continuing Progress Towards Tailored Therapy in Lung Cancer?
	08/11/2009	Can Emerging Targeted Strategies Improve Outcomes in Advanced NSCLC?
	08/11/2009	State-of-the-Art Targeted Therapeutic Strategies for Advanced NSCLC: Front-Line and Maintenance Settings
	08/11/2009	Scanning the Horizon: An Up-to-Date Look at Potential Therapies for Advanced Recurrent/Refractory NSCLC
	08/11/2009	Ushering in an Era of Personalized Medicine in Advanced NSCLC: Predictive and Prognostic Markers as Guides for Treatment Selection
	05/04/2009	Applying Cell Histology, Disease-Related and Patient-Specific Characteristics to Therapy Selection in Metastatic NSCLC
	08/29/2008	Latest Data From Chicago Provide New Insight Into the Evolving Role of Cytotoxic and Targeted Therapies in Early-Stage NSCLC
	08/28/2008	More Than Brief Intervention: Updating Smoking Cessation Treatment for Pulmonary Patients
	03/19/2008	Tackling a Silent Threat: Implications and Management of Peripheral Artery Disease
	03/19/2008	Peripheral Artery Disease: A Highly Prevalent Disease Remains Underdiagnosed and Undertreated
	03/19/2008	Diagnosing Peripheral Artery Disease: The Importance of Using the Ankle-Brachial Index
	03/19/2008	Understanding Evidence-Based Guidelines for the Treatment of Peripheral Artery Disease